第1届
Display of Difficult Targets
-呈现困难标的的讨论会-
2月19日～20日
由于可能可以获得结晶构造，对包括离子通道（ion channel）和G蛋白质共轭受容体(CPCR)的膜蛋白质之理解有大幅进展。此外，适应能与膜蛋白质一起使用的噬菌体和酵母之研究亦在进行中。此讨论会聚焦于蛋白质的选择、共结晶化、促效药（agonist）结合与活性化、以及发现和精制的手法等，令人期待这些手法有助于因应困难标的药剂之开发。
Who Should Attend: VPs, Directors, Managers, CEOs, CSOs, Professors and Scientists from Large Pharma, Biotechs and Academia working in fields such as Antibody Engineering, R&D, Lead Discovery, Diagnostics, Therapeutics, Biologics and Chemistry.
Topics will include, but are not limited to:
- Insights from crystal structures of membrane proteins
- Antibody selection against membrane proteins
- Expression and purification of multi-pass proteins
- Locking GPCR conformation with ligands or antibodies
- Strategies for drug development
- Evolution of ligands to membrane proteins
The deadline for submission is July 29, 2011.
All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program. Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
